Shareholders Foundation, Inc.

Deadline Upcoming on December 26, 2016 in Lawsuit for Investors in Taro Pharmaceutical Industries Ltd. (NYSE:TARO)

A Deadline is coming up on December 26, 2016in the lawsuit for investors in Taro Pharmaceutical Industries Ltd. (NYSE:TARO) and NYSE:TARO stockholders should contact the Shareholders Foundation.

 

San Diego, CA -- (SBWIRE) -- 12/13/2016 -- The Shareholders Foundation announced that a deadline is coming up on December 26, 2016 in the lawsuit filed for investors of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) over alleged securities laws violations by Taro Pharmaceutical Industries.

Investors who purchased shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) have certain options and there are strict and short deadlines running. Deadline: December 26, 2016. NYSE:TARO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

According to the complaint filed in the U.S. District Court for the Southern District for New York the plaintiff alleges on behalf of purchasers of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) common shares between July 3, 2014 and September 9, 2016, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between July 3, 2014 and September 9, 2016 the defendants made false and/or misleading statements and/or failed to disclose that since 2014 Taro Pharmaceutical has colluded with other pharmaceutical companies to keep the price of generic products artificially high, that the foregoing conduct violated federal antitrust laws, that in turn, Taro Pharmaceutical's revenues during the Class Period were the result of illegal conduct, and that as a result, Taro Pharmaceutical's public statements were materially false and misleading at all relevant times.

On September 9, 2016, Taro Pharmaceutical Industries Ltd. disclosed it and two of its senior officers received grand jury subpoenas in connection with a federal antitrust investigation into generic drug pricing.

Shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) declined from $145.20 per share in August 2016 to as low as $101.02 per share on October 20, 2016.

Those who purchased shares of Taro Pharmaceutical Industries Ltd. have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com